Amgen Inc.
Amgen Inc. is a United States company whose shares trade on NASDAQ under the ticker AMGN. Annual market values are recorded across 1983–2026, ranging from $56.3 million to $230.71 billion. Its market capitalisation stands near $230.78 billion as of October 2026. Market values combine exchange closes with the latest reported share count.Read More ▼Show Less ▲
Listed market data
AMGN · NASDAQ · weeklyHistory →- Market cap
- $231 B
- Share price
- USD 427.19
- 1Y change
- +30.5%
- 3Y change
- +71.4%
- Since first close
- ×1,619
from 1983-06
Financial history
Full market history- 2026-10USD 438.34$231 B
- 2026-09USD 421.51$222 B
- 2026-08USD 429.88$226 B
- 2026-07USD 385.16$203 B
- 2026-06USD 362.12$191 B
- 2026-05USD 336.79$177 B
- 2026-04USD 346.25$182 B
- 2026-03USD 351.85$185 B
- 2026-02USD 388.16$204 B
- 2026-01USD 341.88$180 B
- 2025-12USD 327.31$172 B
- 2025-11USD 345.46$182 B
In the press
All coverage →5 latest headlines11- Lobbying Update: $3,150,000 of AMGEN INC lobbying was just disclosed - Quiver Quantitativewww.quiverquant.com2026-10-21
- Amgen, AstraZeneca Detail Phase III Data For Tezspire’s Likely Third Indication - Scripinsights.citeline.com2026-10-20
- Amgen Inc (AMGN) Shares Surge 3.3% -- What GF Score of 85 Tells Investors - GuruFocuswww.gurufocus.com2026-10-20
- AstraZeneca/Amgen Drug Shows Significant Remission in Eosinophilic Esophagitis Study - Benzingawww.benzinga.com2026-10-20
- Amgen, AstraZeneca report phase 3 results for Tezspire in eosinophilic esophagitis - Seeking Alphaseekingalpha.com2026-10-20
Related
Similar listed companies
- Eli Lilly and Company· $1.1 T
- Johnson & Johnson (J&J)· $616 B
- Allergan Aesthetics· $504 B
- AbbVie Inc.· $504 B
- F. Hoffmann-La Roche AG· $372 B
- Merck Animal Health· $360 B
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: NASDAQ: AMGN